Medios AG | WebDisclosure

PRESS RELEASE

published on 05/12/2025 at 18:58, 10 months 13 days ago

Medios repositions itself for the next phase of its corporate development
Medios AG announces changes in Executive Board as part of corporate development transition. Founder and CEO to step down, COO to leave company. Focus on profitability and value creation. Professional search for CEO successor initiated

Profitability Executive Board Medios AG Corporate Development CEO Successor
PRESS RELEASE

published on 05/12/2025 at 18:56, 10 months 13 days ago

EQS-Adhoc: Changes to the Medios AG Executive Board; Matthias Gärtner will leave the company
Medios AG announces changes to its Executive Board with Matthias Gärtner, CEO, and Mi-Young Miehler, COO, leaving the company under mutual agreement for an organized transition

Executive Board Supervisory Board Medios AG Matthias Gärtner Mi-Young Miehler
BRIEF

published on 03/25/2025 at 07:55, 1 year ago

Medios AG prévoit une croissance continue en 2025

Medios AG Prévisions De Revenus Augmentation De L'EBITDA Croissance 2025 Pharmaceutique Spécialisée
BRIEF

published on 03/25/2025 at 07:55, 1 year ago

Medios AG Projects Continued Growth in 2025

Revenue Forecast Medios AG EBITDA Increase Specialty Pharma 2025 Growth
PRESS RELEASE

published on 03/25/2025 at 07:50, 1 year ago

Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion

Revenue Growth Earnings Forecast Record Year Medios 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year ago

Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Pharmaceutical Industry Medios AG Financial Growth 2024 Results 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year ago

Medios AG annonce une forte croissance de ses bénéfices en 2024 et prévoit de nouveaux gains en 2025

Croissance Financière Medios AG Résultats 2024 Industrie Pharmaceutique Perspectives 2025
PRESS RELEASE

published on 03/04/2025 at 08:50, 1 year ago

Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million

Revenue Outlook Earnings Medios AG Margins
BRIEF

published on 12/12/2024 at 13:32, 1 year 3 months ago

Medios AG ajuste ses prévisions financières pour l'ensemble de l'année

Medios AG Prévisions Financières Marge D'EBITDA Augmentation Des Revenus Spécialité Pharmaceutique
BRIEF

published on 12/12/2024 at 13:32, 1 year 3 months ago

Medios AG Adjusts Full-Year Financial Forecast

Revenue Increase EBITDA Margin Financial Forecast Medios AG Specialty Pharma

Published on 03/26/2026 at 11:07, 38 minutes ago

U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 45 minutes ago

Pivotree Announces Fourth Quarter 2025 Results
Published on 03/26/2026 at 11:00, 45 minutes ago

Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 40 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 50 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

View all ACCESSWIRE

Published on 03/26/2026 at 11:03, 42 minutes ago

EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 45 minutes ago

Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 45 minutes ago

Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 45 minutes ago

ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 45 minutes ago

Une étude indépendante révèle un retour sur investissement de 44 % avec EQS Compliance Cockpit et un amortissement en moins de six mois.

View all EQS

Published on 03/26/2026 at 08:57, 2 hours 47 minutes ago

Communiqué Edenred
Published on 03/26/2026 at 08:57, 2 hours 47 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 4 hours 15 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 4 hours 15 minutes ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 16 hours 51 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026

View all LES ECHOS COMFI WIRE

News